Dashboard
Manage Tickers

ATEX Anterix Inc.

Nasdaq anterix.com


$ 20.76 $ 0.37 (1.82 %)    

Monday, 20-Oct-2025 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 612.40 $ 7.61 (1.26 %)
DIA $ 467.24 $ 5.24 (1.13 %)
SPY $ 671.95 $ 6.91 (1.04 %)
TLT $ 91.61 $ 0.35 (0.38 %)
GLD $ 401.91 $ 14.16 (3.64 %)
$ 20.75
$ 20.50
$ 20.00 x 2
$ 21.59 x 100
$ 20.48 - $ 20.98
$ 20.19 - $ 42.91
136,508
na
388.85M
$ 0.45
$ 13.26
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 06-24-2025 03-31-2025 10-K
3 02-11-2025 12-31-2024 10-Q
4 11-13-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 06-26-2024 03-31-2024 10-K
7 02-14-2024 12-31-2023 10-Q
8 11-13-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 06-14-2023 03-31-2023 10-K
11 02-09-2023 12-31-2022 10-Q
12 10-31-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-26-2022 03-31-2022 10-K
15 02-03-2022 12-31-2021 10-Q
16 11-03-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 06-15-2021 03-31-2021 10-K
19 02-08-2021 12-31-2020 10-Q
20 11-16-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-28-2020 03-31-2020 10-K
23 02-04-2020 12-31-2019 10-Q
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-20-2019 03-31-2019 10-K
27 02-08-2019 12-31-2018 10-Q
28 11-07-2018 09-30-2018 10-Q
29 08-10-2018 06-30-2018 10-Q
30 06-05-2018 03-31-2018 10-K
31 02-06-2018 12-31-2017 10-Q
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 06-06-2017 03-31-2017 10-K
35 02-07-2017 12-31-2016 10-Q
36 11-03-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 06-13-2016 03-31-2016 10-K
39 02-16-2016 12-31-2015 10-Q
40 11-10-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

update-anterix-q1-adj-eps-048-beats-057-estimate-sales-1418m-miss-1508m-estimate
UPDATE: Anterix Q1 Adj. EPS $(0.48) Beats ...
08/12/2025 22:29:47

Anterix (NASDAQ:ATEX) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.57) by 15...

nasdaq-100-sp-500-hit-new-all-time-highs-airlines-jump-whats-moving-markets-tuesday
Nasdaq 100, S&P 500 Hit New All-Time Highs...
08/12/2025 17:19:57

Wall Street is in full rally mode after July’s inflation data eased fears that tariff-related cost pressures were widespread. T...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

top-3-tech-and-telecom-stocks-that-could-blast-off-in-q3
Top 3 Tech And Telecom Stocks That Could B...
07/21/2025 11:21:05

anterix-q4-adj-eps-042-beats-046-estimate-sales-1389m-miss-1711m-estimate
Anterix Q4 Adj. EPS $(0.42) Beats $(0.46) ...
06/24/2025 20:47:14

Anterix (NASDAQ:ATEX) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.46) by 8....

anterix-q4-sales-139m-miss-171m-estimate
Anterix Q4 Sales $1.39M Miss $1.71M Estimate
06/24/2025 20:35:11

Anterix (NASDAQ:ATEX) reported quarterly sales of $1.39 million which missed the analyst consensus estimate of $1.71 million by...

Core News & Articles
Earnings Scheduled For June 24, 2025
06/24/2025 08:32:07

top-3-tech-and-telecom-stocks-that-may-jump-this-quarter
Top 3 Tech And Telecom Stocks That May Jum...
05/05/2025 13:27:22

anterix-launches-its-anterixaccelerator-initiative-with-investment-of-up-to-250m
Anterix Launches Its AnterixAccelerator In...
03/10/2025 11:06:33

jp-morgan-maintains-overweight-on-anterix-raises-price-target-to-67
JP Morgan Maintains Overweight on Anterix,...
02/13/2025 15:52:54

JP Morgan analyst Jerome Darling maintains Anterix (NASDAQ:ATEX) with a Overweight and raises the price target from $61 to $67.

crude-oil-gains-1-us-small-business-optimism-declines-in-january
Crude Oil Gains 1%; US Small Business Opti...
02/11/2025 17:36:04

communications-firm-anterix-initiates-strategic-review-with-morgan-stanley-stock-surges
Communications Firm Anterix Initiates Stra...
02/11/2025 17:28:53

Anterix Inc. shares rise following the company's announcement of a strategic review process with Morgan Stanley. The review...

lattice-semiconductor-selectquote-radiant-logistics-and-other-big-stocks-moving-higher-on-tuesday
Lattice Semiconductor, SelectQuote, Radian...
02/11/2025 15:42:16

anterix-engages-morgan-stanley-to-begin-strategic-review-process-after-receiving-inbound-interest-in-the-company
Anterix Engages Morgan Stanley To Begin St...
02/11/2025 12:20:08

Additionally, Anterix has launched a new industry engagement initiative to address and shorten the time to realization of value...

earnings-scheduled-for-february-11-2025
Earnings Scheduled For February 11, 2025
02/11/2025 08:32:17

anterix-expands-partnership-with-lcra-providing-additional-900-mhz-licenses-for-texas-growth
Anterix Expands Partnership with LCRA, Pro...
01/13/2025 13:37:58

Anterix (NASDAQ:ATEX) and the Lower Colorado River Authority announced today that LCRA has contracted with Anterix to purchase ...

anterix-names-tom-kuhn-as-chairman-of-board-effective-january-1-morgan-obrien-retires-after-more-than-12-years-on-the-board
Anterix Names Tom Kuhn As Chairman Of Boar...
12/30/2024 22:03:31

anterix-q2-2025-gaap-eps-069-misses-052-estimate-sales-1551m-miss-1747m-estimate
Anterix Q2 2025 GAAP EPS $(0.69) Misses $(...
11/13/2024 21:07:20

Anterix (NASDAQ:ATEX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.52) by ...

earnings-scheduled-for-november-13-2024
Earnings Scheduled For November 13, 2024
11/13/2024 08:32:22

anterix-announces-rob-schwartz-will-be-stepping-down-appoints-scott-lang-as-president-and-ceo-effective-november-1-2024
Anterix Announces Rob Schwartz Will Be Ste...
10/08/2024 20:31:09

Lang brings more than 30 years of experience in strategic leadership, innovation, and operational excellence to AnterixWOODLAND...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION